Drug Topics
JULY 28, 2023
Zavegepant (Zavzpret) is the first and only calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray approved by the FDA for acute migraine treatment in adults.
PharmaVoice
JULY 28, 2023
Head honchos at the biggest pharma companies reporting second-quarter earnings dig into the topics du jour.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JULY 28, 2023
A recent study determined over 12,000 screenings would need to be done to identify 1 case of melanoma in racial and ethnic minority populations.
Pharmacy Times
JULY 28, 2023
PT staff discusses health outcomes involving SABI, reduced vascular function, and OBA.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
JULY 28, 2023
Canan Dagdeviren has dedicated her career to creating tools that can capture data from every nook and cranny of the human body. An electrode that reads brain signals in Parkinson’s patients. A tattoo-like patch to detect skin cancer. And now, a bra containing a flexible ultrasound that could one day be used to more comfortably screen for breast cancer.
Pharmacy Times
JULY 28, 2023
The approval of RiVive naloxone hydrochloride nasal spray for nonprescription use provides another tool to help quickly reverse the effects of opioid overdose.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
JULY 28, 2023
Pharmacists play a key role in migraine management, therefore, awareness of menstrual migraine-specific prophylaxis is important.
pharmaphorum
JULY 28, 2023
1000Farmacie Secures $25 Million in Series A Funding Nicole.
Pharmacy Times
JULY 28, 2023
A new study indicates that adults with obesity or who are overweight with weight-related comorbidities can help manage their weight with lifestyle changes in conjunction with specified treatment.
Pharmaceutical Technology
JULY 28, 2023
NS Pharma’s candidate would be the first to target Duchenne Muscular Dystrophy (DMD) patients amenable to exon 44 skipping therapy.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
JULY 28, 2023
It was previously undetermined whether the combination of IVIG and ICI would lead to patient complications or reduced efficacy of the cancer treatment, but 2 successful case reports dispel that belief.
Pharmaceutical Commerce
JULY 28, 2023
CDMO’s Turku addition will span over 69,000 square feet and support the production of ATMPs.
Pharmacy Times
JULY 28, 2023
Thousands more people filled their insulin prescriptions following the introduction of the cap in January 2023, especially compared to those who were not enrolled in Medicare, a new study finds.
STAT
JULY 28, 2023
AstraZeneca said Friday it will buy up a group of early-stage gene therapies from Pfizer, bucking a trend of drugmakers axing programs and exiting a field that had once captured the imagination — and checkbooks — of many pharmaceutical executives. AstraZeneca will pay Pfizer up to $1 billion plus royalties for the portfolio of treatments, none of which has entered clinical trials yet.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
JULY 28, 2023
Community-based pharmacy services are reaching new heights as pharmacists and pharmacy technicians are able to have a larger impact on patient care than ever before.
Fierce Healthcare
JULY 28, 2023
Lobbying groups representing different camps of the healthcare industry have come together to urge the Centers for Medicare & Medicaid Service (CMS) to reconsider “conflicting regulatory propos | The American Hospital Association, American Medical Association and Blue Cross Blue Shield Association penned a joint letter highlighting "conflicting" prior authorization electronic standards and workflows they say will bring industry confusion and unnecessary burden.
Pharmacy Times
JULY 28, 2023
The medical experts discuss strategies to achieve treatment adherence.
Fierce Healthcare
JULY 28, 2023
The time is now 90 seconds to midnight, according to the Doomsday Clock, which scientists use to estimate how close humanity might be to blowing itself up with nuclear weapons. | The world hasn't been this close to nuclear war since the Cold War, say experts. Editors of prestigious medical journals sound a call to disarm.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
JULY 28, 2023
Social determinants of health inhibit optimal impact of MM treatment.
STAT
JULY 28, 2023
WASHINGTON — House Republicans have drafted drug-shortage legislation that differs significantly from the approach Democrats propose to stem shortages of chemotherapies and other critical medicines that hospitals typically use. Republicans on the House Energy and Commerce Committee are focused on what they say are the underlying economic reasons for shortages.
pharmaphorum
JULY 28, 2023
Merck's challenge to Pfizer's Prevnar grows Phil.
The Checkup by Singlecare
JULY 28, 2023
When your healthcare provider places the blood pressure cuff around your arm, you likely hope you won’t have high blood pressure. Hypertension is a common medical condition, but did you know there’s also a possibility your blood pressure could be too low? Turns out, a lot can be revealed as that cuff tightens around your biceps. Blood pressure is a measure of heart and vascular health, specifically the force of blood force flowing through blood vessels.
pharmaphorum
JULY 28, 2023
After cutbacks, Biogen adds new drug with $7.3bn Reata buy Phil.
Drug Store News
JULY 28, 2023
Rite Aid shared its progress across its four key pillars, focused on areas such as environmental sustainability, responsible sourcing, employee benefits and more.
European Pharmaceutical Review
JULY 28, 2023
Publication of results of the Phase III SKYLARK study “is a pinnacle moment in treating postpartum depression ( PDD ),” stated Dr Kristina M Deligiannidis, Professor at the Institute of Behavioral Science at the Feinstein Institutes, the trial’s principal investigator, lead author of the paper. The study investigated oral 50mg, 14-day neuroactive steroid zuranolone pill as a treatment for perinatal or postpartum depression.
STAT
JULY 28, 2023
Biogen on Friday said it would acquire Reata Pharmaceuticals, the maker of an approved therapy for a rare neurological condition, in a deal worth $7.3 billion. The transaction price of $172.50 per share is a nearly 60% premium from Reata’s share price at Thursday’s close. The deal is expected to close by the end of the year. Reata, based in Plano, Texas, won its first approval in February for a drug that treats Friedreich’s ataxia.
Drug Store News
JULY 28, 2023
The digital platform offers an assortment of wine varietals and global wine beverages ranging in price.
STAT
JULY 28, 2023
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is rather modest. We plan to take in a football match, catch up on our reading, and promenade with the official mascots. And if time permits, we may hold a listening party, where the rotation would include this , this , this and this.
Drug Store News
JULY 28, 2023
James Kehoe is departing as global CFO; Manmohan Mahajan has been named interim global CFO.
Fierce Healthcare
JULY 28, 2023
This week, a visitor opened fire at Legacy Good Samaritan Medical Center in Portland, killing a security guard and injuring a nurse. | Following increases in both aggression towards nurses and mass shootings, stakeholders are debating whether new tech or old solutions can make a difference.
Drug Store News
JULY 28, 2023
Medicine Cabinet aims to enable consumers to keep track of their medications, find the lowest prices and earn rewards for staying on track.
Pharmaceutical Commerce
JULY 28, 2023
The pharma and biotech exec will begin his role on Aug. 1.
Drug Store News
JULY 28, 2023
To celebrate National Mustard Day, French’s is pairing the flavor of its iconic mustard with the classic Skittles candy.
Expert insights. Personalized for you.
469 
Let's personalize your content